NWMP
GILD icon

Noble Wealth Management PBC’s Gilead Sciences GILD Stock Holding History

Noble Wealth Management PBC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.34K Hold
9
– – ﹤0.01% 636
2026
Q2 		$1.14K Buy
+9
New +$1.19K ﹤0.01% 680
2025
Q1 		$4.48K Hold
40
– – ﹤0.01% 449
2024
Q4 		$3.69K Buy
+40
New +$3.6K ﹤0.01% 415

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Noble Wealth Management PBC's GILD Position: Q3 2026 in Review

Noble Wealth Management PBC held its Gilead Sciences (GILD) position steady in Q3 2026 at 9 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Noble Wealth Management PBC first reported a position in GILD in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.48K in Q1 2025. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Noble Wealth Management PBC held 9 shares of Gilead Sciences worth $1.34K as of Q3 2026.
  • Noble Wealth Management PBC left its Gilead Sciences share count unchanged in Q3 2026.
  • Gilead Sciences made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #636 holding.
  • Noble Wealth Management PBC first reported a position in Gilead Sciences in Q4 2024 and has held it in 4 quarters since.
  • Noble Wealth Management PBC's Gilead Sciences position peaked at $4.48K in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.